Received Jan 20, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5J959 | — |
Patient may have received partial dose. Error may have occurred where patient did not receive adjuvant with antigen. Risk management performed analysis and collaborated with MD with Infectious Disease. Patient will be offered repeat vaccination.